The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.
Kingsley J, Kumarasamy N, Abrishamian L, Bonten M, Igbinadolor A, Mekebeb-Reuter M, Rosa J, Solai Elango D, Lopez P, Fustier P, Goncalves S, Knutson CG, Kukkaro P, Legenne P, Ramanathan K, Rao S, Reshetnyak E, Stavropoulou V, Stojcheva N, Stumpp MT, Tietz A, Soergel M, Chandra R.
Kingsley J, et al. Among authors: fustier p.
Open Forum Infect Dis. 2024 May 3;11(6):ofae233. doi: 10.1093/ofid/ofae233. eCollection 2024 Jun.
Open Forum Infect Dis. 2024.
PMID: 38854392
Free PMC article.